BioSpace News Archive

Business

SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced a new partnership with QIAGEN N.V. (NYSE: QGEN) that will pair QIAseq reagent technology with the SOPHiA DDM™ platform to enhance tumor analysis through next-generation sequencing (NGS).

March 1, 2023
·
6 min read
Business

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call on March 8, 2023

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report fourth quarter and year-end 2022 financial results on Wednesday, March 8, 2023.

March 1, 2023
·
1 min read
Bio NC

Praetego Awarded $0.3M by National Eye Institute to Advance Novel Oral Drug for Diabetic Retinopathy

Praetego Inc. is pleased to announce a $0.3M STTR award from the National Eye Institute.

March 1, 2023
·
2 min read
Pharm Country

Positron Corporation Enters into Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device

Positron Corporation is pleased to announce that it has executed a Clinical Study/Research Agreement with Ochsner Clinic Foundation and Dr. Bober, Director of Molecular Imaging and Nuclear Cardiology at Ochsner Health, for the clinical study of its new PET-CT imaging device, the Affinity™ PET-CT 4D.

March 1, 2023
·
3 min read
Brenus Pharma Announces its Strategic Committee Supporting & Ensuring Its Value-creating Strategic Plan

BRENUS PHARMA, a French private biotechnology start-up specialized in the development of first in class tumor-antigen focused immunotherapies announced the recruitment of its Strategic Committee composed by renowned pharma-industry and biotech executives.

March 1, 2023
·
2 min read
Business

Lumos Pharma Reports Full Year 2022 Financial Results, Provides Clinical Development Updates

Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced financial results for the year ended December 31, 2022.

March 1, 2023
·
15 min read
Pharm Country

Aprea Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Aprea Therapeutics, Inc. announced that it received formal notice from The Nasdaq Stock Market stating that the Company has regained compliance with Nasdaq’s minimum bid price for continued listing on the Nasdaq Global Select Market as set forth in Nasdaq Listing Rule 5450.

March 1, 2023
·
3 min read
Business

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, “Ginkgo”), which is building the leading platform for cell programming and biosecurity, today announced its results for the fourth quarter and year ended December 31, 2022.

March 1, 2023
·
22 min read
Biotech Beach

Avidity Biosciences to Participate in Upcoming March 2023 Investor Conference

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, announced that Avidity management will be participating at the following conference.

March 1, 2023
·
2 min read
Biotech Bay

Invitae to Present at the TD Cowen 43rd Annual Health Care Conference

Invitae, a leading medical genetics company, announced that Ken Knight, president and chief executive officer, will participate in a fireside chat at the TD Cowen 43rd Annual Health Care Conference on Monday, March 6, at 1:30 p.m. Eastern.

March 1, 2023
·
1 min read